MGMA Sharply Criticizes Meaningful Use Stage 3 Proposal

Originally published in the June 3, 2015 issue of MGMA’s Washington Connection
Reprinted with permission from MGMA

MGMA submitted formal comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed rule outlining Stage 3 of the EHR Incentive (meaningful use) Program. The Association made a series of recommendations to make the regulation less burdensome for eligible professionals (EPs), including:

  • Delay finalization of Stage 3 until the impact of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is known and the meaningful use provisions of MACRA are developed through regulation.
  • Delay finalization of Stage 3 until there is actionable data from EP participation in Stage 2 of the Program.
  • Eliminate any Stage 3 objective that would require actions on the part of the patient or other third parties in order for the EP to successfully participate in the Program.
  • Replace the full-year proposed reporting period with consecutive 90-day reporting for all years of the Program.

While CMS previously indicated it would seek to release a final rule this summer, the negative reception to the proposed rule by MGMA and other industry groups could lead to a delay of the final rule. For more information on the Stage 3 proposed rule, read MGMA’s member-benefit outline.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: